PRESCRIBING · PART D · 2024
Total Rx claims
5,571
Beneficiaries
—
Total drug cost
$635K
Distinct drugs
105
Brand share
20.6%
Top prescribed drugs
Atorvastatin Calcium314 claims
Losartan Potassium228 claims
Amlodipine Besylate204 claims
Semaglutide193 claims
Gabapentin176 claims
QUALITY · MIPS · 2024
Final MIPS score
88.2
Quality
71.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.55%
APM Entity
CROSS-REFERENCE